UBS AG - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2014$2,000
-96.0%
800
-94.2%
0.00%
Q2 2014$50,000
+61.3%
13,700
+97.9%
0.00%
Q1 2014$31,000
-50.0%
6,924
-57.0%
0.00%
Q4 2013$62,000
-97.7%
16,113
-97.3%
0.00%
-100.0%
Q3 2013$2,724,000
-0.3%
601,237
+8.1%
0.00%0.0%
Q2 2013$2,731,000556,3000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$13,541,0000.88%
Broadfin Capital, LLC 3,338,570$3,405,0000.21%
Spark Investment Management LLC 229,600$234,0000.03%
Baillie Gifford 6,406,099$6,534,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 349,546$357,0000.01%
A.R.T. Advisors, LLC 80,108$81,0000.00%
Psagot Value Holdings Ltd. 101,876$103,0000.00%
WEDBUSH SECURITIES INC 18,000$18,0000.00%
TFS CAPITAL LLC 31,234$32,0000.00%
VAN ECK ASSOCIATES CORP 106,208$108,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders